News | Press Releases

---

November 18, 2014

Toshiba America Medical Systems Inc. Awarded Innovative Technology Designation for Dose Tracking System at Novation Innovative Technology Expo

Annual Event Identifies Healthcare Products that Improve Patient Outcomes and Enhance Patient and Provider Safety

TUSTIN, Calif., Nov. 18, 2014 – Toshiba America Medical Systems, Inc. announced that its Dose Tracking System (DTS) was awarded the coveted Innovative Technology designation by Novation at its Innovative Technology Expo on Sept. 10, 2014, at the Irving Convention Center, Irving, Texas.

Toshiba’s DTS, which is available for its entire Infinix™ product line, including the Elite, Select and Essential cardiovascular X-ray systems, provides a real-time display that tracks cumulative skin dose distribution, as well as peak skin dose, to provide a safer exam for patients. In addition, enhancements such as expanded bi-plane (frontal and lateral) coverage and enhanced ability to account for tilt and cradle table movement help clinicians track and measure peak skin dose, giving customers the confidence that they are providing the safest, best approach to diagnoses and treatment.

DTS was awarded the Innovative Technology designation following a review by more than 200 attendees from hospitals around the United States who serve on a Novation council or task force and participated in the expo. These key opinion leaders indicated that Toshiba’s DTS offered incremental benefits over other products available on the market.

“Toshiba’s DTS helps provide a safer patient exam, allowing clinicians to focus on accurate diagnosis and better care,” said Olya Carter, RN and Senior Clinical Manager at Novation. “DTS’s 85 percent approval rating from attendees reflects the technology’s benefit to patient safety and its effectiveness.”

“Our customers rely on fast, accurate data to make real-time diagnoses and decisions,” said David Sloop, director, X-ray Vascular Business Unit, Toshiba. “DTS is a first-of-its-kind technology that improves patient safety and experience, as well as giving clinicians confidence that their decisions are backed by solid data to keep their patients safe and procedures effective.”

This new designation will also identify Toshiba’s Dose Tracking System as an awarded Innovative Technology product within Novation’s online contract catalog, which is accessible by the more than 100,000 members and affiliates of VHA Inc., UHC, Children’s Hospital Association and Provista served by Novation. This heightened visibility will encourage further consideration by members accessing this agreement.

To learn more about Novation’s Innovative Technology program, visit www.novationco.com/expertise/technology.

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.

About Toshiba

Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical products and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation” and is contributing to the achievement of a world in which people everywhere live in a safe, secure and comfortable society.

Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.

About Novation, Recipient of the Ethisphere Institute’s Ethics Inside Certification

Novation is the nation’s leading health care services company, focused on revolutionizing operational performance for more than 100,000 members and affiliates of VHA Inc., UHC, Children’s Hospital Association and Provista LLC. Novation’s progressive approach to cost performance, data and intelligence, and integrated advisory solutions helps health care providers envision and advance new models of cost-effective, high-quality care. Headquartered in Irving, Texas, Novation is committed to the highest standards of ethical behavior and twice has been honored with the Ethisphere Institute’s coveted Ethics Inside^® Certification, and has been named three years consecutively to Ethisphere’s World’s Most Ethical Companies list. To learn more about Novation, please visit novationco.com and follow @NovationNews on Twitter.

###